Cost of revenue · 2018–2025
Rigel Pharmaceuticals cost of revenue
$19.6M+5.2% · FY2025
Rigel Pharmaceuticals (RIGL) reported $19.6M in cost of revenue for fiscal 2025, +5.2% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $19.6M | +5.2% | Open → |
| FY20242024-12-31 | $18.6M | +162.3% | Open → |
| FY20232023-12-31 | $7.1M | +306.5% | Open → |
| FY20222022-12-31 | $1.7M | +61.5% | Open → |
| FY20212021-12-31 | $1.1M | +21.0% | Open → |
| FY20202020-12-31 | $895,000 | −1.2% | Open → |
| FY20192019-12-31 | $906,000 | +215.7% | Open → |
| FY20182018-12-31 | $287,000 | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +82.9%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Rigel Pharmaceuticals cost of revenue |url=https://companiesranked.com/en/company/rigel-pharmaceuticals/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Rigel Pharmaceuticals cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/rigel-pharmaceuticals/cost-of-revenueBibTeX
@misc{companiesranked-en-company-rigel-pharmaceuticals-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Rigel Pharmaceuticals cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/rigel-pharmaceuticals/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001034842-26-000015 · March 3, 2026
{{cite web |title=Rigel Pharmaceuticals cost of revenue — 10-K (0001034842-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1034842/000103484226000015/rigl-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.